Ikena Oncology, Inc. revenue breakdown overview

Ikena Oncology, Inc. revenue for the last year amounted to 9.16 M USD, the most of which — 9.16 M USD — came from its highest performing source at the moment, Novel Cancer Therapies, the year earlier bringing 15.62 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Ikena Oncology, Inc. 9.16 M USD, and the year before that — 15.62 M USD.